HMOX1 and familial pancreatic carcinoma: Marked induction of HO-1 expression was also found in pancreatic cancer cells upon gemcitabine treatment or radiation; targeted knockdown of HO-1 expression led to growth inhibition of pancreatic cancer cells and made tumor cells significantly more vulnerable to radiotherapy and chemotherapy[31,52].